A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million HIV-negative people in the country use the jab every year over the next eight ...

Stocks gave up an early rally and briefly went negative as big swings rocked Wall Street for a second straight day. The S&P 500 erased nearly all of a 4% ...